全文获取类型
收费全文 | 7903篇 |
免费 | 413篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 47篇 |
儿科学 | 123篇 |
妇产科学 | 49篇 |
基础医学 | 1063篇 |
口腔科学 | 177篇 |
临床医学 | 519篇 |
内科学 | 2226篇 |
皮肤病学 | 234篇 |
神经病学 | 580篇 |
特种医学 | 281篇 |
外科学 | 1339篇 |
综合类 | 62篇 |
预防医学 | 236篇 |
眼科学 | 58篇 |
药学 | 529篇 |
中国医学 | 14篇 |
肿瘤学 | 825篇 |
出版年
2023年 | 36篇 |
2021年 | 138篇 |
2020年 | 92篇 |
2019年 | 104篇 |
2018年 | 144篇 |
2017年 | 125篇 |
2016年 | 165篇 |
2015年 | 157篇 |
2014年 | 206篇 |
2013年 | 253篇 |
2012年 | 411篇 |
2011年 | 453篇 |
2010年 | 269篇 |
2009年 | 244篇 |
2008年 | 409篇 |
2007年 | 470篇 |
2006年 | 434篇 |
2005年 | 431篇 |
2004年 | 455篇 |
2003年 | 396篇 |
2002年 | 440篇 |
2001年 | 248篇 |
2000年 | 232篇 |
1999年 | 241篇 |
1998年 | 85篇 |
1997年 | 55篇 |
1996年 | 58篇 |
1995年 | 60篇 |
1994年 | 60篇 |
1993年 | 51篇 |
1992年 | 177篇 |
1991年 | 144篇 |
1990年 | 147篇 |
1989年 | 134篇 |
1988年 | 93篇 |
1987年 | 90篇 |
1986年 | 60篇 |
1985年 | 64篇 |
1984年 | 49篇 |
1983年 | 43篇 |
1982年 | 24篇 |
1981年 | 30篇 |
1980年 | 25篇 |
1979年 | 44篇 |
1978年 | 25篇 |
1973年 | 30篇 |
1972年 | 33篇 |
1971年 | 26篇 |
1970年 | 29篇 |
1969年 | 28篇 |
排序方式: 共有8362条查询结果,搜索用时 31 毫秒
1.
2.
3.
Manabu Fujimoto Jun Asai Yoshihide Asano Takayuki Ishii Yohei Iwata Tamihiro Kawakami Masanari Kodera Masatoshi Abe Masahiro Amano Ryuta Ikegami Taiki Isei Zenzo Isogai Takaaki Ito Yuji Inoue Ryokichi Irisawa Masaki Ohtsuka Yoichi Omoto Hiroshi Kato Takafumi Kadono Sakae Kaneko Hiroyuki Kanoh Masakazu Kawaguchi Ryuichi Kukino Takeshi Kono Monji Koga Keisuke Sakai Eiichi Sakurai Yasuko Sarayama Yoichi Shintani Miki Tanioka Hideaki Tanizaki Jun Tsujita Naotaka Doi Takeshi Nakanishi Akira Hashimoto Minoru Hasegawa Masahiro Hayashi Kuninori Hirosaki Hideki Fujita Hiroshi Fujiwara Takeo Maekawa Koma Matsuo Naoki Madokoro Sei-Ichiro Motegi Hiroshi Yatsushiro Osamu Yamasaki Yuichiro Yoshino Andres James LE Pavoux Takao Tachibana Hironobu Ihn Japanese Dermatological Association Guidelines 《The Journal of dermatology》2020,47(10):1071-1109
The Japanese Dermatological Association prepared guidelines focused on the treatment of skin ulcers associated with connective tissue disease/vasculitis practical in clinical settings of dermatological care. Skin ulcers associated with connective tissue diseases or vasculitis occur on the background of a wide variety of diseases including, typically, systemic sclerosis but also systemic lupus erythematosus (SLE), dermatomyositis, rheumatoid arthritis (RA), various vasculitides and antiphospholipid antibody syndrome (APS). Therefore, in preparing the present guidelines, we considered diagnostic/therapeutic approaches appropriate for each of these disorders to be necessary and developed algorithms and clinical questions for systemic sclerosis, SLE, dermatomyositis, RA, vasculitis and APS. 相似文献
4.
Takaharu Ikeda Tamihiro Kawakami Yoshihiro Arimura Naoko Ishiguro Akihiro Ishizu Fuyu Ito Toshiko Ito-Ihara Naoko Okiyama Sachiko Ono Kazuo Suzuki Koji Sugawara Mariko Seishima Masanari Kodera Maiko Tanaka Minoru Hasegawa Fukumi Furukawa Yukie Yamaguchi Ayumi Yoshizaki Revised Committee for guidelines for the management of vasculitis vascular disorders of the Japanese Dermatological Association 《The Journal of dermatology》2020,47(5):534-537
We developed a questionnaire to examine the findings of cutaneous arteritis among dermatological specialists experienced in vasculitis as certified by the Committee for guidelines for the management of vasculitis and vascular disorders of the Japanese Dermatological Association. We sent a questionnaire to 12 dermatological facilities identified through the revised Committee for guidelines for the management of vasculitis and vascular disorders of the Japanese Dermatological Association. Retrospective data obtained from 84 patients at the 12 dermatological facilities between 2012 January 2016 December were evaluated. The 84 patients were categorized into two groups, a systemic steroid treatment group (group 1, n = 52) and a no systemic steroid treatment group (group 2, n = 32). C-reactive protein in group 1 patients was significantly higher than that in group 2 patients. Frequency of fever, arthritis, myalgia- and peripheral neuropathy in group 1 was significantly higher than that in group 2. We propose that these symptoms could serve as early markers for the transfer from cutaneous arteritis to systemic polyarteritis nodosa. We further suggest that patients who are subsequently associated with cerebral hemorrhage and infarction, who are originally diagnosed as having cutaneous arteritis, could progress to systemic polyarteritis nodosa. The study demonstrated that it is important for dermatologists to detect these findings early in order to establish an accurate diagnosis and a timely treatment. 相似文献
5.
Guide for medical professionals (i.e. dermatologists) for the management of Rhododenol‐induced leukoderma 下载免费PDF全文
Chikako Nishigori Yumi Aoyama Akiko Ito Kayoko Suzuki Tamio Suzuki Atsushi Tanemura Masaaki Ito Ichiro Katayama Naoki Oiso Yuji Kagohashi Shinichi Sugiura Kazuyoshi Fukai Yoko Funasaka Toshiharu Yamashita Kayoko Matsunaga 《The Journal of dermatology》2015,42(2):113-128
Because some users develop depigmentation after the use of melanogenesis‐inhibiting products containing the quasi‐drug ingredient Rhododenol, Japanese Dermatological Association (JDA) established a Special Committee on the Safety of Cosmetics Containing Rhododenol on July 17, 2013 and management guide for dermatologists has been updated on the website in order to delineate the diagnostic criteria for Rhododenol‐induced leukoderma and provides a broad guide for standard treatment based on current knowledge. This guide is produced on the basis of the guide (version 7) updated on June 20, 2014 in the website. Rhododenol‐induced leukoderma refers to depigmentation of varying severity that develops after the use of cosmetics containing Rhododenol, mainly at the site of use. In most cases, repigmentation of part or all the affected area is evident after discontinuation. Histopathologically cellular infiltration around the hair follicles and melanophages are present in most cases. The number of melanocytes in the lesion is declined but not totally absent in most cases. Rhododenol itself is a good substrate for tyrosinase, resulting in the formation of Rhododenol metabolites (e.g., Rhododenol quinone). Melanocytes are damaged by Rhododenol metabolites during the subsequent metabolic process. The continued use of cosmetics containing Rhododenol thus induces tyrosinase activity‐dependent cytotoxicity in melanocytes in the epidermis at application sites, resulting in decreasing the amount of melanin produced by melanocytes; the addition of some other factor to this process is believed to subsequently cause the decrease or disappearance of melanocytes themselves from the epidermis. 相似文献
6.
7.
Tetsuji Terazawa Takeshi Kato Masahiro Goto Katsuya Ohta Shingo Noura Hironaga Satake Yoshinori Kagawa Hisato Kawakami Hiroko Hasegawa Kazuhiro Yanagihara Tatsushi Shingai Ken Nakata Masahito Kotaka Masayuki Hiraki Ken Konishi Shiro Nakae Daisuke Sakai Yukinori Kurokawa Toshio Shimokawa Taroh Satoh 《The oncologist》2021,26(1):17-e47
Lessons Learned
- Panitumumab monotherapy showed favorable efficacy and feasibility in the treatment of frail or elderly patients with RAS wild‐type unresectable colorectal cancer.
- It is especially effective for left‐sided tumors; therefore, panitumumab as first‐line treatment could be an additional therapeutic option for frail elderly patients, particularly in those who are unsuitable for upfront oxaliplatin‐based or irinotecan‐based combination regimens.
8.
9.
Tetsuji Terazawa Jin Matsuyama Masahiro Goto Ryohei Kawabata Shunji Endo Motohiro Imano Shoichiro Fujita Yusuke Akamaru Hirokazu Taniguchi Mitsutoshi Tatsumi Sang-Woong Lee Yoshitaka Kurisu Hisato Kawakami Yukinori Kurokawa Toshio Shimokawa Daisuke Sakai Takeshi Kato Kazumasa Fujitani Taroh Satoh 《The oncologist》2020,25(2):119-e208